CHRISTOPHER GORDON: Open Payments
NPI 1649908880 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $191 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: SYMPLICITY G3, LEQVIO, VERQUVO, LifeVest, ICLUSIG.
Industry payments across TX — which companies pay providers there.
